Equities

Shield Therapeutics PLC

STX:LSE

Shield Therapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)4.80
  • Today's Change0.05 / 1.05%
  • Shares traded3.05m
  • 1 Year change-50.77%
  • Beta1.5809
Data delayed at least 20 minutes, as of Sep 27 2024 16:01 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments143.4016
Total Receivables, Net114.524.73
Total Inventory3.201.762.21
Prepaid expenses2.902.50--
Other current assets, total------
Total current assets311223
Property, plant & equipment, net0.670.240.41
Goodwill, net------
Intangibles, net171436
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets492760
LIABILITIES
Accounts payable4.051.74--
Accrued expenses8.779.98--
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.210.110.21
Other current liabilities, total0.701.010.15
Total current liabilities14134.56
Total long term debt207.250
Total debt207.350.21
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities34204.56
SHAREHOLDERS EQUITY
Common stock155.374.57
Additional paid-in capital199169167
Retained earnings (accumulated deficit)(190)(158)(109)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(8.45)(10)(7.66)
Total equity156.5455
Total liabilities & shareholders' equity492760
Total common shares outstanding782267222
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.